Die Juvenile myelomonozyäre Leukämie ist ein Erkrankung, die durch Mutationen des NF1-Gens ausgelöst wird. Die Mutationen können somatische oder Keimbahnmutationen sein. Im letzteren Fall erfolgt eine dominante Vererbung.
1. |
De Filippi P et al. (2009) Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia. |
2. |
Sakaguchi H et al. (2013) Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. |
3. |
Klinakis A et al. (2011) A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. |
4. |
Abdel-Wahab O et al. (2009) Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. |
5. |
Jankowska AM et al. (2009) Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. |
6. |
Flotho C et al. (2008) Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. |
7. |
Schubbert S et al. (2006) Germline KRAS mutations cause Noonan syndrome. |
8. |
Jongmans M et al. (2005) Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature. |
9. |
Tartaglia M et al. (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. |
10. |
Magnusson MK et al. (2001) Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. |
12. |
Ross TS et al. (1998) Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). |
13. |
Niemeyer CM et al. (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) |
14. |
Gelsi-Boyer V et al. (2009) Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. |
15. |
Pathak A et al. (2015) Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family. |
16. |
Pérez B et al. (2010) Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. |
17. |
Muramatsu H et al. (2010) Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. |
18. |
Loh ML et al. (2009) Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. |
19. |
Matsuda K et al. (2007) Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. |
20. |
OMIM.ORG article Omim 607785 |
21. |
Orphanet article Orphanet ID 86834 |